文献速递临床生化临床免疫

免疫比浊法测定血清糖缺失转铁蛋白鉴别酒精性与非酒精性肝病

Determination of serum carbohydrate-deficient transferrin by a nephelometric immunoassay for differential diagnosis of alcoholic and non-alcoholic liver diseases.
PubMed 文献 · Clin Chim Acta · 2018-06-27

本研究评估直接免疫比浊法测定血清糖缺失转铁蛋白(CDT)对酒精性与非酒精性肝病的鉴别诊断价值,并与γ-谷氨酰转移酶(GGT)比较。样本来自305名受试者,包括122例酒精性肝病和102例非酒精性肝病患者。结果显示酒精性肝病患者血清CDT百分比显著高于非酒精性肝病,CDT特异性优于GGT;在GGT正常的酒精性肝病患者中6例CDT显著升高,而GGT升高的非酒精性肝病患者CDT均在参考区间内。结论认为该免疫法有助于识别GGT无应答的饮酒者并排除非酒精性肝病中过量饮酒的可能,尚需大规模前瞻性研究确认。

要点

  • 血清CDT百分比在酒精性肝病中显著高于非酒精性肝病。
  • CDT鉴别酒精性与非酒精性肝病的特异性优于GGT。
  • CDT可识别GGT正常的酒精性肝病患者及排除非酒精性肝病中的过量饮酒。

核心结论

  • 该简单CDT免疫比浊法有助于检测所谓GGT无应答的饮酒者,并排除表观非酒精性肝病中过量饮酒的可能。

研究设计与样本

  • 研究获取305名受试者血清样本,包括122例酒精性肝病患者和102例非酒精性肝病患者。
  • 血清CDT水平以占总转铁蛋白的百分比表示。

主要发现

  • 酒精性肝病患者血清CDT百分比显著高于非酒精性肝病患者。
  • CDT鉴别酒精性与非酒精性肝病的特异性优于GGT。
  • 8例酒精性肝病患者GGT正常,其中6例CDT显著升高。
  • 25例非酒精性肝病患者GGT升高,其CDT水平均在参考区间内。

临床怎么用

  • 在GGT正常的疑似酒精性肝病患者中,可检测CDT以辅助识别过量饮酒。
  • 对于GGT升高的非酒精性肝病患者,CDT在参考区间内有助于排除过量饮酒的致病作用。

局限性

  • 需要大规模前瞻性研究进一步确认CDT的诊断效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carbohydrate-deficient transferrin is a biological marker of excessive drinking. The aim of this study was to evaluate the diagnostic value of a direct nephelometric immunoassay for the differential diagnosis of alcoholic and non-alcoholic liver diseases in comparison with gamma glutamyl transferase. METHODS: Serum samples were obtained from 305 subjects, including 122 patients with alcoholic and 102 cases with non-alcoholic liver diseases. Serum levels of carbohydrate-deficient transferrin were expressed as a percentage of total transferrin. RESULTS: Serum % carbohydrate-deficient transferrin levels were significantly higher in patients with alcoholic than with non-alcoholic liver diseases. Carbohydrate-deficient transferrin had better specificity than gamma glutamyl transferase to differentiate between alcoholic and non-alcoholic liver diseases.There were 8 alcoholic liver disease patients with normal gamma glutamyl transferase levels, and carbohydrate-deficient transferrin was significantly elevated in 6 of them. On the other hand, there were 25 non-alcoholic liver disease patients with elevated gamma glutamyl transferase levels; their carbohydrate-deficient transferrin levels were within the reference intervals in all cases. CONCLUSION: This simple carbohydrate-deficient transferrin immunoassay is useful to detect so-called gamma glutamyl transferase non-responding drinkers and also to exclude the possible role of excessive drinking in apparently non-alcoholic liver diseases. A large-scale prospective study is needed to further confirm the diagnostic utility of carbohydrate-deficient transferrin.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Nomura F, Kanda T, Seimiya M, et al. Determination of serum carbohydrate-deficient transferrin by a nephelometric immunoassay for differential diagnosis of alcoholic and non-alcoholic liver diseases. Clin Chim Acta. 2018. PMID: 29958893. doi:10.1016/j.cca.2018.06.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。